Posted 1 mo agoFirst seen 4 h ago
Principal Biologist
·Paris, FR·via Teamtailor
Posted by Aqemia on 13 October 2026, 40 days ago. Still on their Teamtailor board when we checked 53 min ago.
senior8+ yrs
What the posting is about
The Principal Biologist will lead biological target identification and validation for novel drug discovery programs, focusing on oncology and immuno-oncology. Responsibilities include guiding early-stage projects, designing screening workflows, and collaborating with cross-functional teams to advance clinical candidates. Experience in small-molecule drug discovery and hands-on wet-lab expertise are required for this mission-driven role.
Your experience, ready for this role
Answer a few questions about your real work. Review the additions and download your CV.
Read out of the posting
Levelsenior
Experience asked8+ years
EmploymentNot stated
LocationParis, FR
Work arrangementNot stated
Visa sponsorshipNot stated
SalaryNot extracted, check the posting
Posted2026-10-13
Found viateamtailor, direct from their system
We saw it 1 month after it went up.
The posting, as the company wrote it
About AQEMIA
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI , our proprietary molecule-invention platform, which uniquely combines cutting-edge science with advanced technology. Powered by physics-based modeling, statistical mechanics, and generative AI, QEMI allows our teams to design novel drug candidates from first principles.
What makes AQEMIA different is our commitment to true innovation: our research is dedicated to the invention of new molecular entities, not the refinement of existing ones. We focus on inventing never-before-seen molecules , without relying on experimental data, and advancing them into a growing pipeline of proprietary programs and strategic partnerships with leading pharmaceutical companies.
Our most advanced preclinical programs are currently in the in vivo optimization stage, targeting diseases still waiting for effective treatments, offering our teams the opportunity to work on science that can make a real difference in people’s lives.
For more information, visit AQEMIA.com , our WTTJ Page , and our LinkedIn .
About our team
AQEMIA brings together a diverse, multidisciplinary team of 80+ professionals based in Paris and London. Our scientists and engineers, including chemists, physicists, machine learning experts, and software engineers, work side by side to push the boundaries of early-stage drug discovery.
This close collaboration across disciplines is central to our approach, enabling us to tackle complex scientific challenges from first principles and translate cutting-edge ideas into novel therapeutic candidates. At AQEMIA, team members are encouraged to contribute their expertise, learn from one another, and play an active role in shaping the future of drug invention.
About the Drug Discovery Team
The Drug Discovery Sciences team combines expertise in medicinal chemistry, computational chemistry, biology, and translational science .
Working at the intersection of AI-driven drug design, molecular simulations, and experimental science, the team is responsible for driving scientific excellence across AQEMIA’s drug discovery programs and delivering clinical candidates.
They develop and apply innovative methodologies ensuring that scientific insights translate into high-quality therapeutic opportunities.
Partnering closely with Platform, Engineering, and Program teams, they play a critical role in advancing novel small-molecule therapeutics from concept to clinical candidate.
The role
Join AQEMIA in a role where you will help shape our rapidly expanding portfolio of small molecule programs across diverse therapeutic areas, beginning with oncology and immuno-oncology. This is a unique chance to build a pipeline working closely with the VP of biology, and multidisciplinary teams to accelerate the discovery of clinical candidates. You’ll become part of a dedicated team focusing on providing biological support across the AQEMIA portfolio.
Responsibilities
Drive the identification, validation, and selection of novel biological targets aligned with clear unmet medical needs
Contribute to early-stage project ideation by providing deep biological insight and a strong understanding of the drug discovery value chain
Guide programs from early discovery into the AQEMIA pipeline, supporting progression toward proof of concept
Design, implement, and maintain screening cascades to enable efficient compound evaluation and decision-making
Partner with project teams to provide biological expertise, identify risks, and support data-driven prioritization
Manage and collaborate with external CROs to define experimental strategies and ensure generation of high-quality, decision-enabling datasets
Foster cross-functional collaboration, integrating biology with chemistry, modeling, and platform teams
Qualifications
PhD in biological sciences (e.g., pharmacology, molecular biology, chemical biology, biochemistry) or equivalent industry experience
Strong experience in small molecule drug discovery, including progression from hit identification to candidate nomination
Significant industry experience (typically ~8+ years) in early-stage drug discovery and project ideation
Demonstrated expertise in oncology and/or immuno-oncology
Solid understanding of experimental biology, with hands-on wet lab experience to effectively guide and challenge external partners
Proven ability to apply rigorous, data-driven thinking in a multidisciplinary environment
Nice‑to‑Have
Experience working in a Contract Research Organization-based or highly outsourced R&D model
Track record of contributing to innovative drug discovery strategies aligned with business objectives
Experience in project or portfolio management across complex, cross-functional teams
Strong ability to anticipate and mitigate scientific and strategic risks
Familiarity with translational biology and biomarker strategies
Why Join Us?
At AQEMIA, we work for a mission: joining us means having your own impact on changing the way drugs are discovered, and helping to shape the direction of our fast-growing company and team.
Expanding Drug Discovery Pipeline : Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.
World-Class Interdisciplinary Team : work alongside exceptional talent at the intersection of technology and life sciences. Our teams combine deep expertise in AI, physics-based modeling, biology, and medicinal chemistry to push the boundaries of innovation.
DeepTech Recognition : AQEMIA is proud to be part of the French Tech 40 and France 2030 , highlighting our role as a key player in Europe’s DeepTech ecosystem.
Prime Location with Flexibility : Our offices are located in the heart of Paris and London (King’s Cross) , with flexible work arrangements including up to two remote days per week.
Strong Financial Backing : $100M raised from leading European and International investors
We may use artificial intelligence (AI) tools to support parts of the hiring process, such as reviewing applications, analyzing resumes, or assessing responses and identifying potential inconsistencies or verification signals in application materials based on available information. These tools assist our recruitment team but do not replace human judgment. Final hiring decisions are ultimately made by humans. If you would like more information about how your data is processed, please contact us.
Why this page exists
We read companies’ own hiring systems every hour, 2,463 of them, and show a job the hour it opens instead of when a job board gets around to indexing it. We saw it 1 month after it went up.
The feed is free. No card, no trial to expire.
A free account and your résumé first, no card